Cardiology

Dr. Gregory Weiss reflects on the impact of isolation and loneliness on older patients during the COVID-19 pandemic.

Anti-TNFs, vedolizumab, ustekinumab, thiopurines, and 5-ASA were all linked to a lower risk of myocardial infarctions.

An analysis of the Dallas Heart Study from UTSW details how use of CAC scoring can help determine what patients would stand to benefit from aspirin use for primary prevention.

An analysis of data from women treated at Columbia University Irving Medical Center details outcomes in pregnant women with cardiovascular disease treated by a cardio-obstetrics care team.

Results of an analysis of data from the SWEDEHEART and SOReg registries describe reductions in MACE and other health markers associated with metabolic surgery in severely obese patients with a history of myocardial infarction.

The double-blind trial reported on long-term cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.

An analysis of a Swedish obesity study with more than 20 years of follow-up data is detailing differences in life expectancy among patients who undergo bariatric surgery versus those opting for usual care.

An analysis of data from more than 9 million women details the increased odds of developing gestational diabetes, gestational hypertension, and other complications associated with having polycystic ovary syndrome.

Results from FIDELIO-DKD suggest finerenone was associated with reductions in progression of chronic kidney disease and potential improvements in cardiovascular health.

Our latest emergency department minute quiz from Brady Pregerson, MD, features a woman in her 20s with heart palpitations. Can you determine the correct diagnosis?

Dr. Albert discusses how preventative care and access to health care are important in closing health discrepancies.

Our latest emergency department minute quiz from Brady Pregerson, MD. Can you determine the correct diagnosis?

Dr. Albert discusses some ways to close the racial outcome gaps in cardiology.

Practical Cardiology advisory board member Tsuyoshi Kaneko, MD, reflects on 3 studies examining topics related to TAVR from late-breaking sessions at TCT Connect 2020.

Results of the SCOPE II trial from TCT Connect offer insight into the head-to-head comparison of ACURATE neo valve versus the CoreValve Evolut R System.

Results of REDUCE-IT PCI detail a 34% reduction in 5-point MACE and a 39% reduction in total events among patients receiving icosapent ethyl (Vascepa) in the original trial with a history of PCI.

A Brigham and Women's-led study details trends in incidence, characteristics, and outcomes of surgical explantation following TAVR among patients in the US.

A large population study in Taiwan found regular use of aspirin for prevention of cardiac events increased risk for age-related macular degeneration.

Results from 3-year follow-up of the ULTIMATE study indicate IVUS-guided PCI was associated with lower rates of TVF and stent thrombosis.

The LIVMOR Halo AF Detection System has received 510(k) clearance from the US FDA and becomes the first prescriptible wearable for continuous heart monitoring in patients with atrial fibrillation.

The LIVMOR Halo AF Detection System has received 510(k) clearance from the US FDA and becomes the first prescriptible wearable for continuous heart monitoring in patients with atrial fibrillation.

An analysis suggests 1-in-5 high-risk patients will experience at least one cardiovascular complication within the first year following non-cardiac surgery.

Only 29.5% of sampled CBD users claimed any wellness benefit.

A trial presented at TCT 2020 suggests crushed prasugrel provided no reperfusion benefit when compared against integral tablet in STEMI patients.

An analysis of the Partners YOUNG-MI registry details the increased risk of mortality for facing women after myocardial infarction versus men.

In a recent column, Paul Thompson, MD, offers perspective on deaths due to anomalous coronary artery origin in young athletes with normal stress tests.

A meta-analysis published in JAMA Cardiology details reductions in cardiovascular and kidney outcomes associated with SGLT2 inhibitor use in diabetes patients.

This episode of the Endocrine Outlook podcast features a discussion around the cardiorenal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.

The investigators also found the effects of dapagliflozin were similar in patients with type 2 diabetes and those without type 2 diabetes.

Results of a recent analysis that found ablation was associated with lower risk of dementia compared to medical therapy alone suggest rhythm control could help preserve overall health.